Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
South Korea · Delayed Price · Currency is KRW 10,160
+10 (0.10%)
At close: Sep 11, 2026
Ahn-Gook Pharmaceutical Revenue
Ahn-Gook Pharmaceutical had revenue of 91.85B KRW in the quarter ending June 30, 2026, with 19.56% growth. This brings the company's revenue in the last twelve months to 345.08B, up 18.68% year-over-year. In the year 2025, Ahn-Gook Pharmaceutical had annual revenue of 306.87B with 13.19% growth.
Revenue (ttm)
345.08B
Revenue Growth
+18.68%
P/S Ratio
0.33
Revenue / Employee
882.55M
Employees
391
Market Cap
115.47B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 306.87B | 35.76B | 13.19% |
| Dec 31, 2024 | 271.12B | 37.44B | 16.02% |
| Dec 31, 2023 | 233.68B | 28.29B | 13.77% |
| Dec 31, 2022 | 205.39B | 41.85B | 25.59% |
| Dec 31, 2021 | 163.53B | 20.17B | 14.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| H.PIO | 269.63B |
| DongKoo Bio & Pharma | 241.43B |
| Kyung Dong Pharmaceutical | 201.12B |
| HYUNDAI BIOLAND | 140.70B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 111.72B |
| OPTUS Pharmaceutical | 94.47B |
| KOREA PHARMA | 93.94B |
| Sam-A Pharm. | 72.28B |